|Beckman Coulter - Translating Science into Patient Care: New Results on Early Sepsis Indicator Performance in Real-life Clinical Settings
Welcome to our Virtual Corporate Workshop.
- The workshop presentations are listed below. You may watch each presentation in any order at any time during the ISLH 2020 Virtual Meeting.
- Please click the "Scan Badge" button to the right if you would like to leave your information with us so that we may contact you in the future.
- Scanning your badge will also enter you into the ISLH Virtual Bingo game.
Sepsis is a complex and severe syndrome associated with a dysregulated immune response against infection, affecting more than 30 million patients worldwide. Early detection of sepsis or infection, which may progress to sepsis, is extremely important as it can improve patient outcomes and save money. Beckman Coulter technology with near-native state cellular analysis made it possible to bring the new sepsis biomarker, Early Sepsis Indicator (ESId), to the hematology platform. With this innovation today, the hematology laboratory plays a vital role in rapidly identifying septic patients or those who are at high risk of developing sepsis. We invite you to join Beckman Coulter’s ISLH 2020 workshop to learn the latest news on ESId performance in the real-life clinical settings at Lin-Kou Medical Center in Taiwan and ASAN Medical Center in Seoul, Korea. §: WHO https://www.who.int/sepsis/en/ More session information can be found here.